Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021
ALXN Stock Chart and Intraday Price
ALXN Stock Data
| Asset Type | ETF |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drugs |
ALXN Articles
Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
Alexion Pharmaceutical shares shot up on Monday after it was announced over the weekend that the company would be acquired by AstraZeneca.
Published:
Monday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, American Electric Power, BJ's Wholesale Club, Clorox, HCA Healthcare, Shake Shack, USBancorp, Walt Disney and Xpeng.
Published:
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Friday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Callaway Golf, Facebook, Illumina, iRobot, Six Flags, Starbucks, Twitter and Yandex.
Published:
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft, Pfizer and Wynn Resorts.
Published:
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic selling...
Published:
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
Published:
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
Published: